Hansoh Pharmaceutical Group Company financials at a glance
| Year | Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2018 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$8.68B | HK$8.69B | HK$9.94B | HK$9.38B | HK$0.00M | HK$7.72B | HK$0.00M |
| GM % | Gross Margin % |
|
91.51% | 90.76% | 91.24% | 90.73% | 0.00% | 92.19% | 0.00% |
| OM | Operating Margin |
|
32.02% | 31.91% | 28.39% | 27.79% | 0.00% | 28.99% | 0.00% |
| EPS | Earnings Per Share |
|
HK$0.45 | HK$0.44 | HK$0.44 | HK$0.44 | HK$0.46 | HK$0.00 | |
| Div. | Dividends |
|
HK$0.10 | HK$0.07 | HK$0.07 | HK$0.10 | HK$0.10 | HK$0.00 | HK$0.00 |
| PR % | Payout Ratio % |
|
22.22% | 15.91% | 15.91% | 22.73% | 21.74% | 0 | 0 |
| Sha. | Shares |
|
5788.61m | 5918.99m | 5918.99m | 5920.76m | 5923.74m | 0m | 0m |
| OCF | Operating Cash Flow |
|
HK$3.33B | HK$2.39B | HK$2.58B | HK$2.74B | HK$0.00M | HK$2.07B | HK$0.00M |
| FCF | Free Cash Flow |
|
HK$2.75B | HK$962.83M | HK$2.10B | HK$2.47B | HK$3.56B | HK$1.69B | HK$0.00M |
| FCFS | Free Cash Flow Per Share |
|
HK$0.50 | HK$0.16 | HK$0.35 | HK$0.41 | HK$0.00 | HK$0.34 | HK$0.00 |